Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3855ad7af59d5808ef0316e0288fc6b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-318 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M3-00 |
filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9b127bc2d9e2ee6fc0cd8321e06ed53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_672b8e11a619aa59f1664afa04cd55d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8cd1cd131b3f5c3663c47fa37de3ce8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d9279703a2dc83651323ee5f641f288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d236205e8b5102ccb46a6a5d744cf31b |
publicationDate |
2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2029194-A2 |
titleOfInvention |
Characterization and modulation of physiologic response using baroreflex activation in conjunction with drug therapy |
abstract |
A method and device for delivering and monitoring baroreflex and drug therapy to manage hypertension. The method includes providing an implanted medical device configured to automatically detect drug-related effects on the autonomic nervous system including the steps of measuring a physiologic status of the autonomic nervous system at desired intervals, logging the physiologic status of the autonomic nervous system at desired intervals, monitoring the measured and logged physiologic status of the autonomic nervous system for any changes and correlating the changes to a corresponding drug administration time. The device includes an implanted baroreflex activation device capable of administering one or more hypertension treatment drugs including a controller that activates and adjusts therapy delivery, a baroreflex activation therapy delivery device, a drug therapy delivery device and a device that senses physiologic parameters. |
priorityDate |
2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |